Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Remed Pharma is a Belgian pharmaceutical company specializing in the development, manufacturing, and distribution of high-quality generic medicines. The company primarily focuses on supplying essential medicines to international markets, with a strong presence in Africa, Southeast Asia, and Latin America. Their product portfolio encompasses a wide range of therapeutic areas, including antibiotics, analgesics, vitamins, and treatments for tropical diseases. Remed Pharma operates in compliance with international Good Manufacturing Practice (GMP) standards to ensure the safety and efficacy of its products. By leveraging a robust global distribution network, the company aims to improve access to affordable healthcare in developing regions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Remed Pharma.